| Drug-Target Information | ||||||||
|---|---|---|---|---|---|---|---|---|
| Drug Name | Target Name | Drug Type | Target Type | Source | Drug MeSHID | Interaction Score | Drug Status | Target Action |
| pf-04691502 | serine/threonine-protein kinase mtor | NA | Successful target | TTD , DGIDB | Endometrial Carcinoma[MeSHID:D016889] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] |
0.14 | phase 2 | unknown |
| pf-04691502 | serine/threonine-protein kinase mtor | NA | Successful target | TTD , DGIDB | Endometrial Carcinoma[MeSHID:D016889] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] |
0.14 | phase 2 | inhibitor |
| pf-04691502 | pi3-kinase gamma | NA | Successful target | TTD , DGIDB | Endometrial Carcinoma[MeSHID:D016889] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] |
0.11 | phase 2 | unknown |
| pf-04691502 | pi3-kinase gamma | NA | Successful target | TTD , DGIDB | Endometrial Carcinoma[MeSHID:D016889] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] |
0.11 | phase 2 | inhibitor |
| click here to return to the previous page | ||||||||